Tekla Healthcare Investors (NYSE:HQH) — Market Cap & Net Worth
Market Cap & Net Worth: Tekla Healthcare Investors (HQH)
Tekla Healthcare Investors (NYSE:HQH) has a market capitalization of $1.06 Billion ($1.06 Billion) as of September 19, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #8665 globally and #2483 in its home market, demonstrating a -1.43% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tekla Healthcare Investors's stock price $21.44 by its total outstanding shares 55510323 (55.51 Million). Also see Tekla Healthcare Investors (HQH) total assets for a full breakdown of the balance sheet.
Tekla Healthcare Investors Market Cap History: 2015 to 2026
Tekla Healthcare Investors's market capitalization history from 2015 to 2026. Data shows growth from $748.69 Million to $1.19 Billion (4.38% CAGR). Also see HQH cash generation efficiency for how efficiently the company converts equity into cash flow.
Tekla Healthcare Investors Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tekla Healthcare Investors's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest Tekla Healthcare Investors stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
10.53x
Tekla Healthcare Investors's market cap is 10.53 times its annual revenue
Latest Price to Earnings (P/E) Ratio
10.66x
Tekla Healthcare Investors's market cap is 10.66 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $580.59 Million | $4.80 Million | -$56.02 Million | 120.92x | N/A |
| 2017 | $673.70 Million | $123.06 Million | $121.28 Million | 5.47x | 5.55x |
| 2018 | $585.47 Million | $70.97 Million | $69.20 Million | 8.25x | 8.46x |
| 2019 | $742.20 Million | $-143.63 Million | -$145.29 Million | -5.17x | N/A |
| 2020 | $926.32 Million | $242.92 Million | $241.20 Million | 3.81x | 3.84x |
| 2021 | $1.00 Billion | $157.10 Million | $155.18 Million | 6.37x | 6.45x |
| 2022 | $827.50 Million | $-192.26 Million | -$194.23 Million | -4.30x | N/A |
| 2023 | $837.60 Million | $58.12 Million | $56.33 Million | 14.41x | 14.87x |
| 2024 | $890.94 Million | $10.77 Million | $184.95 Million | 82.73x | 4.82x |
| 2025 | $1.05 Billion | $99.81 Million | $98.61 Million | 10.53x | 10.66x |
Competitor Companies of HQH by Market Capitalization
Companies near Tekla Healthcare Investors in the global market cap rankings as of September 19, 2026. Review Tekla Healthcare Investors (HQH) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Tekla Healthcare Investors by market ranking:
- BlackRock Inc (NYSE:BLK): Ranked #142 globally with a market cap of $166.07 Billion USD.
- Blackstone Group Inc (NYSE:BX): Ranked #281 globally with a market cap of $94.05 Billion USD.
- KKR & Co. Inc. (NYSE:KKR): Ranked #299 globally with a market cap of $88.70 Billion USD.
- Brookfield Corporation (TO:BN): Ranked #312 globally with a market cap of $85.27 Billion USD ( CA$117.88 Billion CAD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #142 | BlackRock Inc | NYSE:BLK | $166.07 Billion | $1069.78 |
| #281 | Blackstone Group Inc | NYSE:BX | $94.05 Billion | $124.96 |
| #299 | KKR & Co. Inc. | NYSE:KKR | $88.70 Billion | $98.81 |
| #312 | Brookfield Corporation | TO:BN | $85.27 Billion | CA$52.52 |
Tekla Healthcare Investors Historical Marketcap From 2015 to 2026
Between 2015 and today, Tekla Healthcare Investors's market cap moved from $748.69 Million to $ 1.19 Billion, with a yearly change of 4.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.19 Billion | +13.20% |
| 2025 | $1.05 Billion | +18.01% |
| 2024 | $890.94 Million | +6.37% |
| 2023 | $837.60 Million | +1.22% |
| 2022 | $827.50 Million | -17.27% |
| 2021 | $1.00 Billion | +7.99% |
| 2020 | $926.32 Million | +24.81% |
| 2019 | $742.20 Million | +26.77% |
| 2018 | $585.47 Million | -13.10% |
| 2017 | $673.70 Million | +16.04% |
| 2016 | $580.59 Million | -22.45% |
| 2015 | $748.69 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Tekla Healthcare Investors was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.06 Billion USD |
| MoneyControl | $1.06 Billion USD |
| MarketWatch | $1.06 Billion USD |
| marketcap.company | $1.06 Billion USD |
| Reuters | $1.06 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tekla Healthcare Investors
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs funda… Read more